T-group (topology)
211.1.1 Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase
Ligands and drugs
4,345
Member domains
1,968
with ligand contacts (≤ 4 Å)
45.3% of members
1,501
with DrugDomain annotations
34.5% of members
607
with a DrugBank compound
14.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 211.1.1 belongs to X-group 211 Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase, which binds 8.9 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00828 | FCN | Fosfomycin | 38 |
| DB00290 | BLM | Bleomycin | 36 |
| DB01702 | DHY | 2-(3,4-Dihydroxyphenyl)Acetic Acid | 30 |
| DB03407 | 4NC | 4-Nitrocatechol | 30 |
| DB08307 | NTD | 2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE | 26 |
| DB02923 | BPY | Biphenyl-2,3-Diol | 14 |
| DB03345 | BME | Mercaptoethanol | 13 |
| DB01235 | DAH | Levodopa | 12 |
| DB00143 | GSH | Glutathione | 10 |
| DB04120 | MCT | 4-Methyl-1,2-Benzenediol | 10 |
| DB00151 | CYS | Cysteine | 8 |
| DB00529 | PPF | Foscarnet | 8 |
| DB03130 | GNB | S-P-Nitrobenzyloxycarbonylglutathione | 8 |
| DB03309 | NHE | N-cyclohexyltaurine | 8 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 8 |
| DB03602 | GSB | S-benzylglutathione | 8 |
| DB03900 | TBU | tert-butanol | 8 |
| DB07914 | HPX | 2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid | 8 |
| DB11091 | PEO | Hydrogen peroxide | 8 |
| DB02850 | 869 | DAS869 | 7 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| COmetal | COBALT (II) ION | 365 |
| MNmetal | MANGANESE (II) ION | 337 |
| FE2metal | FE (II) ION | 318 |
| P6G | HEXAETHYLENE GLYCOL | 297 |
| ZNmetal | ZINC ION | 231 |
| CL | CHLORIDE ION | 148 |
| FEmetal | FE (III) ION | 146 |
| NImetal | NICKEL (II) ION | 67 |
| CAmetal | CALCIUM ION | 48 |
| FCN | FOSFOMYCIN | 43 |
| BLM | BLEOMYCIN A2 | 40 |
| MGmetal | MAGNESIUM ION | 39 |
| 4NC | 4-NITROCATECHOL | 30 |
| DHY | 2-(3,4-DIHYDROXYPHENYL)ACETIC ACID | 30 |
| 92X | 1,5-dimethyl-3-(2-methylphenyl)-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-quinazoline-2,4-dione | 28 |
| NTD | 2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE | 27 |
| 94L | 3-(2,6-dimethylphenyl)-1-methyl-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-quinazoline-2,4-dione | 24 |
| A81 | 6,6'-(4-nitro-1H-pyrazole-3,5-diyl)bis(3-bromopyrazolo[1,5-a]pyrimidin-2(1H)-one) | 20 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 18 |
| BME | BETA-MERCAPTOETHANOL | 17 |